0002064452-25-000001.txt : 20250428 0002064452-25-000001.hdr.sgml : 20250428 20250428152246 ACCESSION NUMBER: 0002064452-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250428 DATE AS OF CHANGE: 20250428 EFFECTIVENESS DATE: 20250428 FILER: COMPANY DATA: COMPANY CONFORMED NAME: J2 Health, Inc. CENTRAL INDEX KEY: 0002064452 ORGANIZATION NAME: EIN: 874307816 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-544620 FILM NUMBER: 25879719 BUSINESS ADDRESS: STREET 1: 244 5TH AVENUE STREET 2: SUITE A241 CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: 917-597-9841 MAIL ADDRESS: STREET 1: 244 5TH AVENUE STREET 2: SUITE A241 CITY: NEW YORK STATE: NY ZIP: 10001 D 1 primary_doc.xml X0708 D LIVE 0002064452 J2 Health, Inc. 244 5TH AVENUE SUITE A241 NEW YORK NY NEW YORK 10001 917-597-9841 DELAWARE None None Corporation true 2021 Joshua Poretz 244 5th Avenue Suite A241 New York NY NEW YORK 10001 Executive Officer Director Other Decline to Disclose 06b false 2025-03-12 false true SAFEs, and the Equity Securities Issuable upon conversion of such SAFEs. false 0 1008690 1008690 0 false 5 0 0 0 Offering proceeds will be used, in part, for operational expenses of the Issuer, which will include, among other expenses, salaries of Related Persons. false J2 Health, Inc. /s/ Joshua Poretz Joshua Poretz Chief Executive Officer 2025-04-28